Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors and PD-1 and CTLA-4 Combination Immunotherapy

89 views
June 10, 2019
0 Comments
Login to view comments. Click here to Login